第五屆年度 ECD 醫學研討會，紐約州紐約市

2017 年 10 月 26 日

2017-MS-Group-Photo_All-attendees-300x200

紐約 2017 年醫學研討會合照

研討會摘要

2017 年年度 ECD 醫學研討會共有來自 8 個國家的約 65 名醫療專業人士出席。會中發表了 18 份口頭摘要以及另外 5 份海報展示。Neal Rosen 醫學博士兼哲學博士發表了受邀演講。晚間招待會為這群知識淵博、且皆有志於深入了解 Erdheim-Chester 疾病的醫師與科學家提供了交流時間，以支持目前及未來的合作。

含研討會議程的計畫

介紹

以下新增的簡報內容，希望能幫助其他有興趣進一步瞭解 ECD 的醫師與研究人員。ECDGA 感謝醫學界為改善 ECD 患者照護所做的努力與貢獻。

Presenter	Presentation Slides
Ankush Bhatia, MD	Single-agent dabrafenib for BRAFV600E-mutated histiocytosis
Riccardo Biavasco, MD	BRAFV600E expression in hematopoietic progenitors leads to myeloid skewing and histiocytosis
Pascale Chasseur, MD	A cytologic diagnosis of BRAFV600E Erdheim-Chester disease on pericardial fluid
Marina Ferrarini, MD	3-D culture of BRAF and KRAS-mutated Erdheim-Chester disease tissues: impact of kinase inhibitors
Aaron Goodman, MD	Genomics of Erdheim Chester Disease: Implications for Precision Treatment with Targeted Therapy
Gaurav Goyal, MBBS	Efficacy of Biologic Agents in the Treatment of Erdheim-Chester Disease
Gaurav Goyal, MBBS	Increased prevalence of myeloid neoplasms in patients with Erdheim-Chester disease
Julien Haroche, MD, PhD	BRAF V600E mutation is associated with a cardiac and neurological phenotype in Erdheim-Chester disease: results from a 165-patient cohort
Filip Janku, MD, PhD	Clinical molecular profiling of archival tumor tissue and cell-free DNA from patients with Erdheim-Chester disease
Augusto Vaglio, MD	Renal and ureteral involvement in Erdheim-Chester disease: analysis of a single centre cohort